August 30, 2010 at 10:45 AM EDT
Genzyme leads drug stocks higher
Genzyme Corp. was the lead advancer among the large-cap drug stocks in early trading, with shares rising almost 4% to $70.16.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here